Skip to content

Clinical study on residual pain after verteboplasty for osteoporotic thoracolumbar compression fracture treated with Dingganren Decoction Mulberry cream formula

Clinical study on residual pain after verteboplasty for osteoporotic thoracolumbar compression fracture treated with Dingganren Decoction Mulberry Paste

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2200006757
Enrollment
Unknown
Registered
2022-11-09
Start date
2022-11-09
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Residual pain after vertebroplasty for osteoporotic thoracolumbar compression fractures

Interventions

Experimental group:ketorolac tromethamine + Rabeprazole + Mulberry cream formula
Experimental group:ketorolac tromethamine + Rabeprazole

Sponsors

Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1) Patients with osteoporosis, clear mind and able to answer and communicate correctly; 2) No gender limitation; 3) Clear indications for surgery without obvious contraindications; 4) Have the ability of independent behavior, can receive rehabilitation guidance, rehabilitation treatment and follow-up in our unit regularly; 5) Performed PKP for the first time; 6) Postoperative VAS score was higher than 3 points; 7) Sign informed consent and cooperate closely.

Exclusion criteria

Exclusion criteria: 1) Vertebral compression fracture caused by violence or high-energy injury (e.g. fall injury, traffic accident injury); 2) Non-fracture pain caused by abdominal viscera, urinary system or other diseases; 3) Pathological fracture caused by infection or metastatic tumor; 4) Spinal cord compression or neurological symptoms caused by fracture, requiring other surgical treatment; 5) Patients who cannot or refuse to undergo surgical treatment due to personal reasons.

Design outcomes

Primary

MeasureTime frame
VAS pain score;

Secondary

MeasureTime frame
oswestry disability index;

Countries

China

Contacts

Public ContactJiqing Wang
zhongguobaicao@163.com17601231101

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026